# US 2022/0284575 A1 · Systems and Methods for Generating Patient-Specific Corneal Cross-Linking Treatment Patterns

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0284575 A1
- Document ID: US20220284575A1
- Status: Published application
- Kind: A1
- Application number: 17/689,515
- Filed: 2022-03-08
- Published: 2022-09-08
- Earliest claimed: 2021-03-08
- Assignees: Avedro, Inc.
- Applicants: Avedro, Inc.
- Inventors: David Usher; Mikhail Smirnov; Behrouz Tavakol; Grace Elizabeth Lytle
- Web page: https://patentgrep.com/patent/US20220284575A1

## CPC

- A61F 9/0079: {using non-laser electromagnetic radiation, e.g. non-coherent light or microwaves}
- G06T 7/0012: {Biomedical image inspection}
- A61B 3/102: {for optical coherence tomography [OCT]}
- A61F 9/008: using laser
- A61F 2009/00893: {Keratoconus}
- A61P 27/02: Ophthalmic agents
- G06T 2207/10101: Optical tomography; Optical coherence tomography [OCT]
- G06T 2207/30041: Eye; Retina; Ophthalmic
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- G06T: IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

An automated process receives input tomography data and generates an optimized (customized) treatment pattern for an individual patient without relying on the physician's analysis and judgment. For example, a method for treating a cornea includes receiving tomographic data for a cornea. The method includes identifying a keratoconic defect in the cornea based on the tomographic data. The method includes segmenting the keratoconic defect into treatment zones based on predefined geometric parameters, wherein the treatment zones indicate where a cross-linking agent is to be applied on the cornea and photoactivated to treat the keratoconic defect.

## Claims

### Claim 1

A method for treating a cornea, comprising:
receiving tomographic data for a cornea;
identifying a keratoconic defect in the cornea based on the tomographic data; and, segmenting the keratoconic defect into treatment zones based on predefined geometric parameters, wherein the treatment zones indicate where a cross-linking agent is to be applied on the cornea and photoactivated to treat the keratoconic defect.

### Claim 2 (depends on 1)

The method of claim 1, further comprising:
applying the cross-linking agent to the cornea; and
delivering, with an illumination system, the illumination to photoactivate the cross-linking agent according to the treatment zones.

### Claim 3 (depends on 1)

The method of claim 1, further comprising specifying different respective doses of photoactivating light to be delivered to the treatment zones.

### Claim 4 (depends on 3)

The method of claim 3, wherein the respective doses of photoactivating light decrease outwardly from an innermost treatment zone.

### Claim 5 (depends on 1)

The method of claim 1, wherein the tomographic data provides topography maps showing at least one of elevation, curvature, or pachymetry.

### Claim 6 (depends on 1)

The method of claim 1, wherein identifying a keratoconic defect in the cornea based on the tomographic data includes generating Zernike coefficients describing deviation of anterior and/or posterior conical surfaces from a reference shape.

### Claim 7 (depends on 1)

The method of claim 1, wherein identifying a keratoconic defect in the cornea based on the tomographic data includes implementing Corneal Location and Magnitude Index (CLMI) analysis to produce estimates for location and severity of the keratoconic defect.

### Claim 8 (depends on 1)

The method of claim 1, wherein segmenting the keratoconic defect into treatment zones includes selecting elevation, curvature, or pachymetry data as a basis for segmentation.

### Claim 9 (depends on 1)

The method of claim 1, wherein segmenting the keratoconic defect into treatment zones includes creating boundaries for the treatment zones based on segmentation data.

### Claim 10 (depends on 1)

The method of claim 1, wherein segmenting the kertoconic defect into treatment zones includes processing boundaries for the treatment zones to at least one of: reduce eccentricity of treatment shapes for the treatment zones, scale up or down treatment shapes for the treatment zones, or modify treatment zone areas.

### Claim 11

A system for treating a cornea, comprising:
an illumination system configured to deliver illumination that activates a photosensitizing agent applied to a cornea; and
a controller configured to control the illumination system, the controller including one or more processors and one or more computer readable media, the one or more processors configured to execute instructions from the computer readable media to cause the controller to:
receive tomographic data for a cornea;
identify a keratoconic defect in the cornea based on the tomographic data;
segment the keratoconic defect into treatment zones based on predefined geometric parameters, wherein the treatment zones indicate where a cross-linking agent is to be applied on the cornea and photoactivated to treat the keratoconic defect; and
cause the illumination system to deliver the illumination to photoactivate the cross-linking agent according to the treatment zones.

### Claim 12 (depends on 11)

The system of claim 11, wherein the illumination is ultraviolet (UV) light.

### Claim 13 (depends on 11)

The system of claim 11, wherein the instructions from the computer readable media further cause the controller to specify different respective doses of photoactivating light to be delivered to the treatment zones.

### Claim 14 (depends on 13)

The system of claim 13, wherein the respective doses of photoactivating light decrease outwardly from an innermost treatment zone.

### Claim 15 (depends on 11)

The system of claim 11, wherein the tomographic data provides topography maps showing at least one of elevation, curvature, or pachymetry.

### Claim 16 (depends on 11)

The system of claim 11, wherein the controller identifies the keratoconic defect in the cornea by generating Zernike coefficients describing deviation of anterior and/or posterior corneal surfaces from a reference shape.

### Claim 17 (depends on 11)

The system of claim 11, wherein the controller identifies the keratoconic defect in the cornea by implementing Corneal Location and Magnitude Index (CLMI) analysis to produce estimates for location and severity of the keratoconic defect.

### Claim 18 (depends on 11)

The system of claim 11, wherein the controller segments the keratoconic defect into treatment zones by selecting elevation, curvature, or pachymetry data as a basis for segmentation.

### Claim 19 (depends on 11)

The system of claim 11, wherein the controller segments the keratoconic defect into treatment zones by creating boundaries for the treatment zones based on segmentation data.

### Claim 20 (depends on 11)

The system of claim 11, wherein the controller segments the keratoconic defect into treatment zones by processing boundaries for the treatment zones to at least one of: reduce eccentricity of treatment shapes for the treatment zones, scale up or down treatment shapes for the treatment zones, or modify treatment zone areas.
